Summary. Directors are not liable for bad outcomes, and that sentence explains most of what fiduciary duty law does. The business judgment rule presumes a disinterested, informed, good-faith decision was proper, and corporate litigation is built around whether a plaintiff can knock that presumption down. This article works through care, loyalty, and the oversight obligation that grew out of Caremark, and shows where each breaks in practice: uninformed sale processes, conflicted transactions that skipped a cleansing procedure, and compliance systems that never existed for a risk central to the business. It also covers exculpation, indemnification, advancement, and D&O coverage — the protections that decide whether a breach costs a director money or costs an insurer money — and closely held companies and LLCs, where the rules differ from what public-company cases teach.

A board approves the sale of the company at a 60% premium after a two-hour meeting, with no written agreement in front of it, no valuation, and no market check. Every director is independent. Nobody is on both sides of the deal. The price is objectively good.

That board lost. Smith v. Van Gorkom, 488 A.2d 858 (Del. 1985), remains the most useful case in this area precisely because the outcome was fine and the process was not. A premium is not a defense to an uninformed decision, and the reason is structural: courts will not second-guess business judgment, so the only thing left to examine is whether a judgment was actually exercised.

That is the organizing idea. Fiduciary law in the United States polices process and conflict, not results. Once you internalize that, the doctrine becomes navigable, and the practical advice becomes obvious: build a record that a judgment was made, by people with nothing to gain, on the basis of information reasonably available.

The presumption everything runs through

Under Delaware law — which most states follow in substance, and which is the reference point for the rest of this article — the business judgment rule is a presumption that in making a business decision the directors acted on an informed basis, in good faith, and in the honest belief that the action taken was in the best interests of the company. Aronson v. Lewis, 473 A.2d 805 (Del. 1984).

It is not a defense the board raises. It is a presumption the plaintiff must rebut, and that allocation is nearly dispositive. If the presumption stands, the court will not review the substance of the decision unless it is so far beyond reason as to amount to waste — a standard almost nothing meets. If the presumption is rebutted, the burden flips to the defendants to prove the transaction was entirely fair, and entire fairness is a standard defendants lose under with some regularity.

What rebuts it. The plaintiff must plead and prove that a majority of the deciding directors were:

  • Interested — they stood on both sides of the transaction or derived a personal benefit not shared by stockholders generally;
  • Not independent — their judgment was subordinated to an interested party through employment, family, business, or personal ties material enough to compromise them;
  • Grossly negligent in becoming informed; or
  • Acting in bad faith — which Delaware treats as a subset of the duty of loyalty rather than a freestanding duty.

Directors decide; the rule follows the decision-maker. Under 8 Del. C. § 141(a), the business of a corporation is managed by or under the direction of its board. The business judgment rule protects that allocation. Note that it is a rule about decisions. A board that fails to act at all — the oversight problem discussed below — is not protected by a presumption about a decision it never made.

Officers owe the same duties. Gantler v. Stephens, 965 A.2d 695 (Del. 2009), settled that officers owe the same fiduciary duties as directors. What officers historically did not have was the benefit of charter exculpation, which until recent amendments to Delaware law was available only to directors. That gap made officers the residual defendant in duty-of-care claims, and it explains why plaintiffs' firms named CEOs and CFOs individually even in cases about board process.

The duty of care, and why it almost never produces liability

The duty of care requires directors to inform themselves of all material information reasonably available before acting, and then to act with the care of an ordinarily prudent person. The liability standard, however, is gross negligence — not ordinary negligence — and gross negligence in this context means something close to reckless indifference or a decision without the bounds of reason.

What actually gets found. Care claims succeed when the record shows the board did not engage:

  • No written materials, or materials distributed at the meeting.
  • No financial advisor, or an advisor whose fairness opinion was not delivered or explained.
  • A meeting so short that deliberation was impossible.
  • A price or term the board could not explain the derivation of.
  • No minutes, or minutes so thin they suggest nothing occurred.

Van Gorkom had all of these. The board approved a merger presented by the CEO who had negotiated the price himself, without seeing the agreement, in a meeting of about two hours, relying on an oral presentation and a twenty-minute talk from the CFO whose numbers had been prepared for a different purpose entirely.

But the exposure is usually theoretical. After Van Gorkom, Delaware enacted 8 Del. C. § 102(b)(7), permitting a charter provision that eliminates director monetary liability for duty-of-care breaches. Nearly every Delaware corporation has one. Exculpation does not reach:

  • breaches of the duty of loyalty;
  • acts or omissions not in good faith or involving intentional misconduct or a knowing violation of law;
  • unlawful distributions under § 174; or
  • transactions from which the director derived an improper personal benefit.

The consequence is that a well-pleaded complaint in a Delaware corporate case is almost always framed as loyalty or bad faith, not care, because care claims get dismissed on the charter provision. A 2022 amendment extended exculpation to certain officers, with an important carve-out: officer exculpation does not apply to claims by or in the right of the corporation, meaning derivative suits. So officers remain exposed where directors are not.

Reliance protects. 8 Del. C. § 141(e) allows directors to rely in good faith on records, and on reports and opinions from officers, employees, board committees, and experts selected with reasonable care. This is the single most useful defensive tool for a board: a fairness opinion, a valuation, a legal opinion, or an accounting report, actually presented and actually discussed, converts a bare decision into an informed one. The reliance must be genuine — a board that receives an opinion it does not read, from an advisor whose conflicts it never asked about, has not relied on anything.

The duty of loyalty

Loyalty is where liability lives. It requires that directors act in the interest of the corporation and its stockholders rather than in their own, and it is not exculpable, not covered by some insurance provisions, and not subject to the deferential presumption once triggered.

Interested transactions

A transaction is interested when a director or officer is on both sides, or receives a benefit not shared with stockholders. The default consequence is entire fairness review: the defendants must prove fair dealing (how the transaction was initiated, structured, negotiated, disclosed, and approved) and fair price (the economic and financial considerations). The two are examined together, but a badly flawed process taints even a defensible price.

8 Del. C. § 144 provides a safe harbor from voidability where the material facts are disclosed and the transaction is approved by disinterested directors, or by disinterested stockholders, or is fair. Practitioners routinely over-read this. Compliance with § 144 historically prevented a transaction from being void or voidable solely because of the conflict; it did not automatically restore business judgment review, though recent Delaware amendments have moved in that direction for certain transactions. Treat the statute as necessary rather than sufficient, and build the record as though entire fairness may apply.

The cleansing devices that actually work.

  • Special committee. A committee of genuinely disinterested and independent directors, empowered to say no and to hire its own advisors, that negotiates at arm's length. Empowerment matters more than composition: a committee that cannot decline the deal is a rubber stamp with better paperwork.
  • Majority-of-the-minority vote. An informed, uncoerced vote of the disinterested stockholders.
  • Both, from the outset. For controlling-stockholder squeeze-outs, Kahn v. M&F Worldwide Corp., 88 A.3d 635 (Del. 2014), restores business judgment review only if the transaction is conditioned ab initio on both an independent, empowered special committee and an informed majority-of-the-minority vote. "Ab initio" is doing real work: bolting the conditions on after negotiations begin does not qualify.
  • Stockholder approval in non-controller deals. Corwin v. KKR Financial Holdings LLC, 125 A.3d 304 (Del. 2015), holds that a fully informed, uncoerced vote of disinterested stockholders restores business judgment review to a post-closing damages claim. The fight in Corwin cases is nearly always about disclosure: "fully informed" means the proxy disclosed the advisor's conflicts, the management projections, and the process.

Corporate opportunity

The classic formulation comes from Guth v. Loft, Inc., 5 A.2d 503 (Del. 1939): a fiduciary may not take for himself a business opportunity that the corporation is financially able to undertake, that is in the corporation's line of business and of practical advantage to it, in which the corporation has an interest or reasonable expectancy, and the taking of which places the fiduciary in a position inimical to his duties.

Practical points that decide these cases:

  • Presentation and refusal. Formally presenting the opportunity to the disinterested board and documenting the refusal is the cleanest defense. Do it in writing, in the minutes.
  • Waiver by charter. 8 Del. C. § 122(17) permits a corporation to renounce, in its certificate or by board action, any interest in specified classes of opportunities. Venture-backed companies use this routinely so that fund-designated directors can invest in adjacent businesses. Draft the renunciation to the actual scope of the investor's activity.
  • Use of corporate resources. Even where the opportunity itself is outside the line of business, developing it with the company's employees, information, or money creates an independent claim.

Good faith and the oversight duty

Delaware treats good faith not as a third duty but as a condition of loyalty. Stone v. Ritter, 911 A.2d 362 (Del. 2006), holds that a failure to act in good faith is a necessary condition to liability but not itself a separate ground; the failure is a breach of loyalty.

Bad faith means an intentional dereliction of duty, a conscious disregard for one's responsibilities — see In re Walt Disney Co. Derivative Litigation, 906 A.2d 27 (Del. 2006), which upheld the board despite a widely criticized severance package precisely because the record showed engagement rather than indifference.

Caremark: the oversight claim that stopped being theoretical

In re Caremark International Inc. Derivative Litigation, 698 A.2d 959 (Del. Ch. 1996), described a director's oversight obligation and called a claim based on it "possibly the most difficult theory in corporation law upon which a plaintiff might hope to win a judgment." For two decades that description held. It no longer does.

The two prongs, as Stone v. Ritter framed them. Liability requires that:

  1. the directors utterly failed to implement any reporting or information system or controls; or
  2. having implemented such a system, they consciously failed to monitor or oversee its operations, thereby disabling themselves from being informed of risks or problems requiring their attention.

In either case the plaintiff must show the directors knew they were not discharging their obligations. Scienter, not negligence.

What changed. Marchand v. Barnhill, 212 A.3d 805 (Del. 2019), sustained a Caremark claim against the board of an ice cream manufacturer after a listeria outbreak that killed three people. The critical reasoning: food safety was mission critical — "essential and mission critical" to a monoline food company — and the board had no committee overseeing it, no regular process by which food safety compliance reached the board, and no board-level record of the topic at all, despite years of failed inspections and positive test results. Compliance with FDA regulation was not the same as board oversight of compliance.

The doctrine that emerged. Post-Marchand cases turn on a two-step inquiry:

  • Is there a mission-critical or centrally important risk? Airplane safety in In re Boeing Co. Derivative Litigation, 2021 WL 4059934 (Del. Ch. Sept. 7, 2021); regulatory compliance for a drug distributor in Teamsters Local 443 Health Services & Insurance Plan v. Chou, 2020 WL 5028065 (Del. Ch. Aug. 24, 2020). Not every risk qualifies; ordinary business risk and even large financial losses generally do not.
  • Did the board have a system directed at that risk, and did it engage with the reports the system produced? Absence of a committee charter, absence of a board reporting line, absence of the topic from minutes, and — most damaging — red flags that reached the board and produced no response.

The practical governance response, which is the reason this article covers the case law in this detail:

  • Identify, in writing, the two or three risks that are existential to this specific company. For a hospital, patient safety. For a bank, credit and BSA/AML. For a payments company, fraud and money transmission licensing. For a manufacturer, product safety.
  • Assign each to a committee or to the full board, in a charter, and put it on a recurring agenda with a defined cadence.
  • Require management reporting against the risk, including negative information. A dashboard that only reports green is evidence against the board, not for it.
  • Minute the discussion. Not verbatim, but enough to show the topic was presented, questioned, and acted on. The single most common evidentiary problem in these cases is that the board did discuss the risk and nobody wrote it down.
  • Escalate and document red flags. A regulatory warning letter, a whistleblower complaint, a failed audit, a recall, a consent decree — each of these should appear in board materials with a documented response.
  • Do not delegate the oversight itself. Hiring a compliance officer is implementation. Oversight is the board's, and it is not satisfied by the existence of a department.

Books-and-records demands are the on-ramp. Nearly every modern Caremark case begins with a 8 Del. C. § 220 demand for books and records, and Delaware courts have pushed plaintiffs to use that tool before filing. Section 220 productions now routinely reach board materials, committee minutes, and in some cases officer-level communications. This changes drafting incentives: board materials are written for a future § 220 production, and a company whose minutes are one line per topic is not protecting itself. It is destroying the evidence that would have protected it.

Sale-of-control and defensive contexts

Two enhanced-scrutiny standards sit between business judgment and entire fairness. They apply to specific transactional contexts.

Unocal — defensive measures. Unocal Corp. v. Mesa Petroleum Co., 493 A.2d 946 (Del. 1985), applies when a board adopts defensive measures in response to a perceived threat. The board must show reasonable grounds to believe a danger to corporate policy and effectiveness existed, and that the response was reasonable in relation to the threat — refined in later cases to require that the response be neither coercive nor preclusive, and fall within a range of reasonableness.

Revlon — sale of control. Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986), holds that once a sale or break-up of the company becomes inevitable, the board's role changes from defender of the corporate bastion to auctioneer charged with getting the best price reasonably available. Revlon does not require an auction; it requires a reasonable process directed at price.

Lyondell Chemical Co. v. Ryan, 970 A.2d 235 (Del. 2009), is the necessary corrective: an imperfect sale process is a care problem, and care problems are exculpated. To hold directors personally liable in a Revlon case, a plaintiff must show conscious disregard of the duty to obtain the best price, not merely a process that could have been better.

Where this matters for private companies. Most closely held company sales are not Revlon cases in any formal sense, but the framework is still the best available checklist: run a process, consider alternatives, document why the chosen path maximized value, and address conflicts — particularly management's post-closing employment and equity, which is the single most common conflict in a middle-market sale and the one most often left undisclosed to minority holders.

Conflicts between stockholder classes. In re Trados Inc. Shareholder Litigation, 73 A.3d 17 (Del. Ch. 2013), is essential reading for venture-backed boards. Directors owe duties to the corporation and to the common stockholders; they do not owe duties to preferred holders beyond their contract. A board dominated by preferred-designated directors that approves a sale delivering the entire proceeds to the liquidation preference must be prepared to justify it. The defendants in Trados ultimately prevailed on fair price — the common was worth nothing — but only after a trial they would rather not have had.

Closely held corporations and LLCs

Public-company doctrine is not the whole picture, and applying it uncritically to a three-owner company produces wrong answers.

Some states impose partner-like duties among shareholders. Massachusetts is the leading example. Donahue v. Rodd Electrotype Co., 367 Mass. 578 (1975), held that shareholders in a close corporation owe one another the "utmost good faith and loyalty" — a partnership standard — and Wilkes v. Springside Nursing Home, Inc., 370 Mass. 842 (1976), added a burden-shifting framework: the controlling group must show a legitimate business purpose, and the minority may then show a less harmful alternative. The classic Wilkes fact pattern — terminating a minority owner's employment, ending distributions, and leaving him with an unmarketable stake — is the everyday reality of small-company disputes.

Delaware declined to follow. Nixon v. Blackwell, 626 A.2d 1366 (Del. 1993), refused to create special judicial rules for minority stockholders in closely held Delaware corporations, reasoning that minority holders can and should protect themselves by contract. That is a drafting instruction, not merely a doctrinal footnote: in Delaware, the stockholders' agreement is the protection, and a minority investor without one has very little.

Many states supply an oppression remedy by statute. Judicial dissolution or a buyout for "illegal, oppressive, or fraudulent" conduct is available in a majority of states, often with an election by the corporation to purchase the petitioner's shares at fair value. The standards — "reasonable expectations" of the minority owner in some states, "burdensome, harsh and wrongful conduct" in others — are worth checking early, because the availability of a statutory buyout reshapes settlement leverage entirely.

LLCs are contractual. 6 Del. C. § 18-1101 permits an operating agreement to expand, restrict, or eliminate fiduciary duties, with the sole floor being the implied contractual covenant of good faith and fair dealing, which may not be eliminated. Practical consequences:

  • Read the operating agreement before analyzing anyone's duties. In Delaware LLCs, the agreement is the law of the entity.
  • Where the agreement is silent, Delaware applies default fiduciary duties analogous to corporate duties.
  • Where duties are eliminated, the implied covenant becomes the whole game — and it is narrow, filling gaps rather than rewriting bargains.
  • Other states differ significantly. The Revised Uniform LLC Act permits limited modification but preserves a core, and some states do not permit elimination at all. Do not assume the Delaware rule travels.

Partnerships. Meinhard v. Salmon, 249 N.Y. 458 (1928), and its "punctilio of an honor the most sensitive" remains the rhetorical high-water mark of fiduciary law, and the modern uniform acts have codified a narrower version: loyalty limited to specified categories, care limited to gross negligence, and the ability to identify by agreement specific types of conduct that do not violate the duty if not manifestly unreasonable.

Who can sue, and how the claim is shaped

Derivative or direct. A claim belongs to the corporation — and must be brought derivatively — if the corporation suffered the harm and would receive the recovery. A claim is direct if the stockholder suffered an injury independent of the corporation's. The test is stated in Tooley v. Donaldson, Lufkin & Jenrette: who suffered the alleged harm, and who would receive the benefit of the recovery. Most fiduciary claims are derivative, and that classification triggers demand requirements, standing rules, and settlement approval — a subject covered in depth in the companion article on shareholder derivative litigation.

Standing runs with the shares. A derivative plaintiff must have owned stock at the time of the wrong and continuously through the litigation. A merger that cashes the plaintiff out generally extinguishes standing, which is why fiduciary claims and change-of-control transactions interact so aggressively.

Creditors. When a corporation is insolvent, creditors may bring derivative claims for breach of fiduciary duty, because they become the residual claimants. Delaware has rejected the idea of a separate "deepening insolvency" tort and has held that there is no direct creditor claim for breach of fiduciary duty — the claim is derivative. Directors of a company approaching insolvency owe their duties to the corporate enterprise, which in practice means maximizing the value of the firm rather than gambling on a recovery that only equity would capture.

The protective stack: exculpation, indemnification, advancement, insurance

Whether a fiduciary breach costs a director anything personally depends on four separate mechanisms, and they fail in different places.

1. Exculpation (charter). Eliminates monetary liability for care breaches. Free, automatic, and useless for loyalty, bad faith, and improper personal benefit. Confirm it is actually in the certificate — a surprising number of older companies never adopted one, and companies that converted from LLCs frequently lack it.

2. Indemnification (bylaws and agreements). 8 Del. C. § 145 permits indemnification of directors and officers who acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the corporation. Two features to get right:

  • Mandatory versus permissive. Bylaws that say the corporation "may" indemnify are worth much less than bylaws that say "shall." A board in a dispute with a former officer will not volunteer.
  • Derivative-suit limits. Indemnification against judgments in a derivative action is not permitted; expenses may be indemnified, and court approval is required where the person has been adjudged liable. This is a structural gap: the very claim most likely to be brought is the one least likely to be indemnified.

3. Advancement. Payment of defense costs as incurred, before the outcome is known, typically subject to an undertaking to repay if indemnification turns out to be unavailable. Advancement is a separate contractual right and Delaware courts enforce it summarily and unsentimentally, even for defendants accused of serious misconduct — the theory being that the contract was made in advance precisely to avoid case-by-case judgment. For any individual director, a standalone indemnification agreement with mandatory advancement is worth more than the bylaws, because bylaws can be amended and agreements cannot be amended unilaterally.

4. D&O insurance. The economic backstop, and the one most often misunderstood.

  • Side A covers individuals where the company cannot indemnify — insolvency, or a derivative judgment. This is the coverage that actually protects a director personally, and dedicated Side A excess limits are worth buying.
  • Side B reimburses the company for indemnification it provides.
  • Side C covers the entity for securities claims.
  • Watch the exclusions: conduct exclusions (usually requiring a final adjudication of fraud or personal profit, which is the version to negotiate for), insured-versus-insured exclusions (with carve-outs for derivative suits brought without company assistance and for bankruptcy trustees — negotiate these), and prior-acts and prior-knowledge provisions.
  • Claims-made timing. Report on time and secure tail coverage in a sale. The most common uninsured D&O loss in private-company deals is a claim asserted after closing under a policy that lapsed at closing with no runoff purchased.

What a board should actually do

A short operational program, in rough priority order.

Before the decision.

  • Circulate materials in advance, with enough time to read them. Same-day distribution is a recurring fact in bad cases.
  • Identify conflicts at the start of the agenda item, not after discussion. Record who disclosed what.
  • Have the conflicted director leave the room for deliberation and vote, and record the departure and return times.
  • Where a conflict is material, form a special committee with real authority and its own counsel and financial advisor — chosen by the committee.
  • Retain advisors selected with reasonable care and ask about their conflicts, including fee arrangements contingent on closing.

During the decision.

  • Ask questions on the record, particularly about alternatives and about the downside case.
  • Insist on seeing management's projections and the assumptions behind them, and on understanding how an advisor's analysis used them.
  • If the decision is significant and the board is not ready, adjourn. Delay is almost never the thing that creates liability.

After the decision.

  • Write minutes that show engagement: topics presented, materials distributed, questions asked, advisors present, conflicts disclosed, votes and recusals. Not a transcript, and not a one-line resolution.
  • Approve minutes at the next meeting and keep a complete, organized book. A § 220 demand will produce these, and gaps are read against the company.
  • Maintain the compliance reporting cadence for mission-critical risks even in quiet periods. The value of the record is that it exists before the crisis.

Structurally.

  • Adopt or update § 102(b)(7) exculpation, including for officers where appropriate.
  • Enter individual indemnification agreements with mandatory advancement.
  • Review D&O limits and Side A annually against actual exposure, not against last year's premium.
  • Renounce corporate opportunities in the charter where investor directors have overlapping activity, and scope the renunciation accurately.
  • For closely held companies, put the real deal in a stockholders' or operating agreement: employment, distributions, transfer restrictions, buy-sell triggers, deadlock breakers, and information rights. Delaware's answer to minority holders is that they should have contracted for protection, and that answer is available only to people who did.

A note on how these cases feel from the inside

Directors who end up as defendants are usually not the ones who did something obviously wrong. They are the ones who were busy, who trusted management, who did not want to be the difficult person in the room, and who assumed that because the company had a compliance function, compliance was handled.

The doctrine, stripped of citations, asks three questions that any director can ask themselves in real time. Do I have anything to gain here that the stockholders do not? Do I actually know enough to decide this, and if not, what would I need? Is there a risk that could destroy this company, and when did the board last hear about it in a way that let us ask questions?

A board that can answer those three questions well is protected by the business judgment rule in the overwhelming majority of cases. A board that cannot is exposed regardless of how good the outcome turns out to be — which is the same lesson Van Gorkom taught, at a 60% premium, forty years ago.

Choosing where these questions get answered

One structural decision precedes all of the above: which state's law governs. The internal affairs doctrine sends questions of fiduciary duty, board authority, and stockholder rights to the law of the state of incorporation, not the state where the company operates or where the plaintiff lives. A California-headquartered company incorporated in Delaware litigates Caremark, not California's variant, subject to a handful of state statutes that purport to reach foreign corporations with local contacts.

Two practical consequences follow. First, forum-selection bylaws work. Delaware corporations routinely adopt bylaws designating the Court of Chancery as the exclusive forum for internal-affairs claims, and courts outside Delaware generally enforce them. Adopting one is a five-minute board action that removes a real risk of multi-forum litigation over the same transaction.

Second, reincorporation changes the substantive rules, and stockholders notice. A move from Delaware to Nevada or Texas alters exculpation, the availability of appraisal, the standard for controller transactions, and in some cases the availability of the oversight claim itself. Those moves are themselves fiduciary decisions, evaluated under whatever standard applies to a board acting where controllers benefit disproportionately. If a board is considering one, the process should look like the process for any conflicted transaction: an independent committee, its own advisors, a documented rationale that is about the corporation rather than about insulating anyone, and disclosure adequate to support whatever stockholder vote is sought.

Primary authority

Fiduciary law is judge-made, which means the statutes tell you less than the opinions do. The short list below is the one most Delaware-facing board disputes actually run on; the equivalents in other states differ at the margins but rarely at the core.

  • 8 Del. C. § 141(a) — the business of the corporation is managed by or under the direction of the board. Every deference doctrine descends from this sentence.
  • 8 Del. C. § 102(b)(7) — the exculpation charter provision, and the reason a duty-of-care claim for money damages usually dies at the pleading stage.
  • 8 Del. C. § 145 — indemnification and advancement, including the mandatory indemnity for a director who succeeds on the merits.
  • Aronson v. Lewis, 473 A.2d 805 (Del. 1984) — the classic statement of the business judgment rule as a presumption, not a defense.
  • Smith v. Van Gorkom, 488 A.2d 858 (Del. 1985) — gross negligence in the decision process, and the case that created the modern deal-process playbook.
  • In re Caremark International Inc. Derivative Litigation, 698 A.2d 959 (Del. Ch. 1996) — the oversight claim, described in the opinion itself as the most difficult theory in corporation law on which to prevail.
  • Stone v. Ritter, 911 A.2d 362 (Del. 2006) — relocates Caremark inside the duty of loyalty by requiring bad faith, which is why exculpation does not reach it.
  • Marchand v. Barnhill, 212 A.3d 805 (Del. 2019) — a Caremark claim that survived, on a board with no committee and no reporting system for the single most critical compliance risk in the business.
  • In re Boeing Co. Derivative Litigation, 2021 WL 4059934 (Del. Ch. 2021) — the modern template for pleading a red-flags oversight failure.
  • Weinberger v. UOP, Inc., 457 A.2d 701 (Del. 1983) and Kahn v. M&F Worldwide Corp., 88 A.3d 635 (Del. 2014) — entire fairness, and the dual cleansing mechanism that restores business judgment review in a controller deal.
  • Unocal Corp. v. Mesa Petroleum Co., 493 A.2d 946 (Del. 1985) and Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986) — the two intermediate standards that apply when the board is defending or selling.
  • Model Business Corporation Act §§ 8.30–8.31 — the standards of conduct and liability adopted in some form by a majority of states.

Related articles

This article is provided for general informational purposes and does not constitute legal advice. Fiduciary standards, exculpation and indemnification rules, oppression remedies, and the permissible modification of duties in LLCs vary materially by state, and Delaware law in this area continues to develop. Consult qualified corporate counsel in the relevant jurisdiction before acting.